Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Total Assets
Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) holds total assets worth CN¥2.43 Billion CNY (≈ $355.94 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 002864 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Total Assets Trend (2013–2025)
This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total assets have evolved over time, based on quarterly financial data. See 002864 book value for net asset value and shareholders' equity analysis.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's total assets of CN¥2.43 Billion consist of 77.6% current assets and 22.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 47.1% |
| Accounts Receivable | CN¥423.39 Million | 18.2% |
| Inventory | CN¥110.82 Million | 4.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥51.93 Million | 2.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Shaanxi Panlong Pharmaceutical Group Lim worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's current assets represent 77.6% of total assets in 2025, an increase from 64.5% in 2013.
- Cash Position: Cash and equivalents constituted 47.1% of total assets in 2025, up from 19.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 18.2% of total assets.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Total Assets
Key competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
China | CN¥2.30 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
China | CN¥925.41 Million |
|
Jw Pharmac
KO:001060
|
Korea | ₩605.27 Billion |
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩449.14 Billion |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.76 | 3.96 | 2.24 |
| Quick Ratio | 3.53 | 3.72 | 2.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.41 Billion | CN¥1.35 Billion | CN¥500.75 Million |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.95 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 1.9% |
| Total Assets | CN¥2.32 Billion |
| Market Capitalization | $324.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's assets grew by 1.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
The table below shows the annual total assets of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.32 Billion ≈ $339.90 Million |
+1.88% |
| 2024-12-31 | CN¥2.28 Billion ≈ $333.64 Million |
+7.29% |
| 2023-12-31 | CN¥2.13 Billion ≈ $310.96 Million |
+10.06% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.53 Million |
+45.15% |
| 2021-12-31 | CN¥1.33 Billion ≈ $194.65 Million |
+14.42% |
| 2020-12-31 | CN¥1.16 Billion ≈ $170.12 Million |
+25.16% |
| 2019-12-31 | CN¥928.88 Million ≈ $135.92 Million |
+13.58% |
| 2018-12-31 | CN¥817.84 Million ≈ $119.68 Million |
+8.62% |
| 2017-12-31 | CN¥752.93 Million ≈ $110.18 Million |
+49.24% |
| 2016-12-31 | CN¥504.50 Million ≈ $73.82 Million |
+16.42% |
| 2015-12-31 | CN¥433.33 Million ≈ $63.41 Million |
+7.99% |
| 2014-12-31 | CN¥401.26 Million ≈ $58.72 Million |
+17.19% |
| 2013-12-31 | CN¥342.39 Million ≈ $50.10 Million |
-- |
About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more